🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

FDA seeks research, public input in fresh move to curb nicotine addiction

Published 2018-03-15, 10:44 a/m
© Reuters.  FDA seeks research, public input in fresh move to curb nicotine addiction

March 15 (Reuters) - The U.S. Food and Drug Administration is seeking public opinion as well as scientific research on the role nicotine plays in cigarette addiction, the agency said on Thursday, as it aims to lower tobacco-related deaths across the country.

The latest steps are part of a comprehensive plan to regulate tobacco and nicotine that the agency announced last summer, FDA Commissioner Scott Gottlieb said in a statement https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm601039.htm.

That plan marked a major shift designed in moving smokers towards potentially less harmful e-cigarettes. FDA is seeking additional research and data for public review, Gottlieb said, as the agency deliberates on developing a nicotine product standard.

Gottlieb said the FDA is also seeking public opinion on topics such as the appropriate maximum nicotine level in cigarettes and if a product standard should be implemented all at once or gradually.

The FDA also plans to seek similar public input and scientific research on the role that flavors such as menthol play in tobacco addiction and also for the regulation of premium cigars, Gottlieb said.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.